CELLECTAR BIOSCIENCES INC's ticker is and the CUSIP is 15117F807. A total of 38 filers reported holding CELLECTAR BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 23.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $572,326 | +1.0% | 228,930 | +60.8% | 0.00% | – |
| Q1 2024 | $566,680 | +258.6% | 142,382 | +149.6% | 0.00% | – |
| Q4 2023 | $158,006 | +4.9% | 57,042 | 0.0% | 0.00% | – |
| Q3 2023 | $150,591 | +35.4% | 57,042 | 0.0% | 0.00% | – |
| Q2 2023 | $111,232 | +36.4% | 57,042 | 0.0% | 0.00% | – |
| Q1 2023 | $81,570 | -16.4% | 57,042 | 0.0% | 0.00% | – |
| Q4 2022 | $97,542 | -49.2% | 57,042 | 0.0% | 0.00% | – |
| Q3 2022 | $192,000 | – | 57,042 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 174,422 | $586,000 | 0.18% |
| ACT CAPITAL MANAGEMENT, LLC | 21,750 | $73,000 | 0.10% |
| Worth Venture Partners, LLC | 41,636 | $140,000 | 0.09% |
| DIFESA CAPITAL MANAGEMENT, LP | 10,000 | $34,000 | 0.02% |
| 1900 WEALTH MANAGEMENT LLC | 12,000 | $40,000 | 0.01% |
| Maven Securities LTD | 25,000 | $84,000 | 0.00% |
| UBS Group AG | 1,650 | $6,000 | 0.00% |
| AllSquare Wealth Management LLC | 18 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 521 | $2,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 44,439 | $149,000 | 0.00% |